- What is AlgaVac's primary focus?
- AlgaVac is an aquaculture biotechnology company that develops an algae-based oral delivery platform for vaccines and disease treatments in fish and other aquaculture species.
- How does AlgaVac's technology work?
- The company uses genetically transformed microalgae as a cell-based production and bio-encapsulation system. This creates an algal powder that can be mixed into feed to deliver vaccines through regular feeding.
- What problem does AlgaVac's platform aim to solve in aquaculture?
- AlgaVac's platform is designed to reduce reliance on manual injectable vaccination, plastic medical consumables, and handling-intensive disease prevention methods in aquaculture.
- When was AlgaVac founded?
- AlgaVac was founded in November 2022.
- What is AlgaVac's current funding stage?
- AlgaVac is currently in the Pre-Funding stage.
- With which organizations has AlgaVac reported proof-of-concept collaborations?
- AlgaVac has reported proof-of-concept collaborations with Virbac, Temasek Polytechnic, and Israel’s Agricultural Research Organization.
- What are the applications of AlgaVac's proof-of-concept collaborations?
- The proof-of-concept collaborations include oral fish vaccine and growth-promoting applications.
